Taiwanese researcher receives US national chemistry award
Wong Chi-huey (翁啟惠), honorary president of the Institute for Biotechnology and Medicine Industry (IBMI), has been selected to receive the
Read MoreWong Chi-huey (翁啟惠), honorary president of the Institute for Biotechnology and Medicine Industry (IBMI), has been selected to receive the
Read MoreA multinational research team led by National Taiwan University (NTU) Hospital recently achieved a significant breakthrough, publishing their findings in
Read MoreTaiwan’s Michael Ming-Chiao Lai, former vice president of Academia Sinica and researcher at its Institute of Molecular Biology, has been announced this year’s winner of the Nikkei Asia Prize in the category of Science, Technology and Innovation.
Read MoreBy Dave Silver
March 31, 2017
A Taiwanese study presented yesterday at an international conference on Alzheimer’s and Parkinson’s diseases suggested that long-term use of the popular diabetes medication Metformin may increase the risk of neurodegenerative disease in patients with type 2 diabetes mellitus, contradicting the results of a large study published just last year following US-based subjects that seemed to show that Metformin exerts a protective effect against the same diseases.